140 related articles for article (PubMed ID: 33393075)
1. Clobetasol propionate 0.05% under occlusion for alopecia areata: Clinical effect and influence on intraocular pressure.
Nomiyama T; Katoh N
Australas J Dermatol; 2021 May; 62(2):e262-e264. PubMed ID: 33393075
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
3. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial.
Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E
JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568
[TBL] [Abstract][Full Text] [Related]
4. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study.
Lalosevic J; Gajic-Veljic M; Bonaci-Nikolic B; Nikolic M
Dermatol Ther; 2015; 28(5):309-17. PubMed ID: 26179196
[TBL] [Abstract][Full Text] [Related]
5. The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata.
Ucak H; Kandi B; Cicek D; Halisdemir N; Dertlıoğlu SB
J Dermatolog Treat; 2012 Dec; 23(6):410-20. PubMed ID: 21787210
[TBL] [Abstract][Full Text] [Related]
6. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
[TBL] [Abstract][Full Text] [Related]
7. Combined intravenous pulse and topical corticosteroid therapy for severe alopecia areata in children: Comparison of two regimens.
Lalosevic J; Gajic-Veljic M; Bonaci-Nikolic B; Stojkovic Lalosevic M; Nikolic M
Dermatol Ther; 2019 Nov; 32(6):e13092. PubMed ID: 31579982
[TBL] [Abstract][Full Text] [Related]
8. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
van der Vleuten CJ; van Vlijmen-Willems IM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
[TBL] [Abstract][Full Text] [Related]
9. Zinc aspartate, biotin, and clobetasol propionate in the treatment of alopecia areata in childhood.
Camacho FM; García-Hernández MJ
Pediatr Dermatol; 1999; 16(4):336-8. PubMed ID: 10515774
[No Abstract] [Full Text] [Related]
10. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the topical FK506 and clobetasol propionate as first-line therapy in the treatment of early alopecia areata.
Jung KE; Gye JW; Park MK; Park BC
Int J Dermatol; 2017 Dec; 56(12):1487-1488. PubMed ID: 28703306
[No Abstract] [Full Text] [Related]
12. Tinea versicolor of the neck as side effect of topical steroids for alopecia areata.
Brandi N; Starace M; Alessandrini A; Piraccini BM
J Dermatolog Treat; 2019 Dec; 30(8):757-759. PubMed ID: 30668183
[No Abstract] [Full Text] [Related]
13. Congenital alopecia areata.
Lenane P; Pope E; Krafchik B
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):8-11. PubMed ID: 15692503
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Single-Blind Trial of Clobetasol Propionate 0.05% Cream Under Silicone Dressing Occlusion Versus Intra-Lesional Triamcinolone for Treatment of Keloid.
Nor NM; Ismail R; Jamil A; Shah SA; Imran FH
Clin Drug Investig; 2017 Mar; 37(3):295-301. PubMed ID: 27888448
[TBL] [Abstract][Full Text] [Related]
15. Comparative study between topical steroid alone versus combined fractional Erbium:YAG laser with topical steroid in treatment of alopecia areata.
Shokeir HA; Yousry A; Ibrahim SMA
Arch Dermatol Res; 2023 Mar; 315(2):241-247. PubMed ID: 36264329
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.
Angelo JS; Kar BR; Thomas J
Indian J Dermatol Venereol Leprol; 2007; 73(1):65. PubMed ID: 17319037
[TBL] [Abstract][Full Text] [Related]
17. The comparison of therapeutic effect of Clobetasol propionate lotion and squill extract in alopecia areata: a randomized, double-blind clinical trial.
Moosavi ZB; Aliabdi M; Golfakhrabadi F; Namjoyan F
Arch Dermatol Res; 2020 Apr; 312(3):173-178. PubMed ID: 31707498
[TBL] [Abstract][Full Text] [Related]
18. Topical clobetasol propionate treatment and cutaneous adverse effects in patients with early-stage mycosis fungoides: an observational study.
Geller S; Myskowski PL
Cutis; 2020 May; 105(5):E27-E32. PubMed ID: 32603400
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors that affect the response to topical treatment in patchy alopecia areata.
Ucak H; Cicek D; Demir B; Erden I; Ozturk S
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):34-40. PubMed ID: 23181708
[TBL] [Abstract][Full Text] [Related]
20. Jet cryotherapy vs clobetasol proprionate lotion in alopecia areata.
Faghihi G; Radan M
Skinmed; 2014; 12(4):209-11. PubMed ID: 25335348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
